title: [Therapy of bronchial asthma during pregnancy].
abstract: Asthma has been reported to occur in 0.4-1% of pregnant women. A number of clinical studies have attempted to clarify the effect of pregnancy on the course of asthma. Taken together, there is little consistent evidence that pregnancy profoundly influences the severity of asthma, except in occasional individuals. The goals of therapy in managing asthma in a pregnant women are identical to those in a nonpregnant woman with asthma. Management of pregnant women with asthma aims at preventing recurrent attacks of wheezing, acute severe asthmatic attacks, and respiratory failure. Recent studies suggest that inflammation in the airway walls may play an important role in the pathogenesis of asthma. It is increasingly apparent that several different cells, particularly eosinophils, lymphocytes, macrophages, produce a variety of mediators that interact in a complex way to produce a number of pathologic effects. Therefore, the primary treatment should involve antiinflammatory drugs. At present, inhaled corticosteroids appear to be the most effective therapy. Cromolyn sodium may also have an antiinflammatory effect. On the other hand, beta 2-sympathomimetics are the most effective bronchodilators available, followed by theophylline. None of these anti-asthma drugs is harmful in usual doses, to either woman or fetus.
authors: Medizinische Universitätsklinik, Innere Medizin V, Homburg.
authors: D
authors: D
authors: Ukena
authors: I
authors: I
authors: Koper
authors: G W
authors: GW
authors: Sybrecht
mesh_terms: D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D000893:Anti-Inflammatory Agents / Q000627:therapeutic use; D001249:Asthma / Q000188:drug therapy* / Q000503:physiopathology; D001993:Bronchodilator Agents / Q000627:therapeutic use*; D004205:Cromolyn Sodium / Q000627:therapeutic use; D004359:Drug Therapy, Combination; D005100:Expectorants / Q000627:therapeutic use; D005260:Female; D005938:Glucocorticoids / Q000627:therapeutic use; D006801:Humans; D010276:Parasympatholytics / Q000627:therapeutic use; D011247:Pregnancy; D011248:Pregnancy Complications / Q000188:drug therapy*; D013256:Steroids
chemical_list: D000900:Anti-Bacterial Agents; D000893:Anti-Inflammatory Agents; D001993:Bronchodilator Agents; D005100:Expectorants; D005938:Glucocorticoids; D010276:Parasympatholytics; D013256:Steroids; D004205:Cromolyn Sodium
vernacular_title: Therapie des Asthma bronchiale in der Schwangerschaft.